# BridgeBio Pharma, Inc. (BBIO)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/BBIO/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 416.96M | $ -316.26M | $ -421.12M | $ 2.49B | $ -2.52B |
| 2025 | $ 514.08M | $ -746.75M | $ -468.54M | $ 2.73B | $ -2.08B |
| 2024 | $ 233.24M | $ -563.13M | $ -556.69M | $ 1.73B | $ -1.47B |
| 2023 | $ 10.06M | $ -695.46M | $ -572.01M | $ 1.74B | $ -1.35B |
| 2022 | $ 86.74M | $ -537.53M | $ -475.68M | $ 1.72B | $ -1.25B |
| 2021 | $ 82.87M | $ -668.66M | $ -649.22M | $ 1.73B | $ -870.41M |
| 2020 | $ 10.51M | $ -571.64M | $ -518.78M | $ 495.79M | $ 57.91M |
| 2019 | $ 52.35M | $ -336.26M | $ -333.95M | $ 91.79M | $ 408.45M |
| 2018 | $ 0 | $ -172.68M | $ -204.47M | $ 54.51M | $ -163.99M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.99 |
| Liabilities / Eq | -1.48 |
| Current Ratio | 1.23 |

## Other views

- [Metrics](https://sponda.capital/en/BBIO.md)
- [Charts](https://sponda.capital/en/BBIO/charts.md)
- [Compare](https://sponda.capital/en/BBIO/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.